VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 559 filers reported holding VALEANT PHARMACEUTICALS INTL in Q3 2015. The put-call ratio across all filers is 1.96 and the average weighting 1.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2015 | $203,000 | -43.1% | 2,000 | 0.0% | 0.07% | -41.7% |
Q3 2015 | $357,000 | -70.5% | 2,000 | -63.3% | 0.12% | -66.6% |
Q2 2015 | $1,211,000 | +11.9% | 5,450 | 0.0% | 0.36% | +14.0% |
Q1 2015 | $1,082,000 | -1.3% | 5,450 | -28.9% | 0.32% | -8.4% |
Q4 2014 | $1,096,000 | +9.1% | 7,660 | 0.0% | 0.34% | +14.7% |
Q3 2014 | $1,005,000 | -25.8% | 7,660 | -28.6% | 0.30% | -23.9% |
Q2 2014 | $1,354,000 | -4.3% | 10,735 | 0.0% | 0.39% | -11.1% |
Q1 2014 | $1,415,000 | +12.3% | 10,735 | 0.0% | 0.44% | +10.8% |
Q4 2013 | $1,260,000 | +12.5% | 10,735 | 0.0% | 0.40% | +7.2% |
Q3 2013 | $1,120,000 | +21.2% | 10,735 | 0.0% | 0.37% | +15.5% |
Q2 2013 | $924,000 | – | 10,735 | – | 0.32% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Brave Warrior Advisors | 5,701,010 | $1,266,479,000 | 36.57% |
Ruane, Cunniff & Goldfarb | 33,884,050 | $7,527,342,000 | 35.90% |
LeVasseur Capital Partners LLC | 188,804 | $41,943,000 | 34.97% |
Pershing Square Capital Management | 19,473,933 | $4,326,134,000 | 29.95% |
FARLEY CAPITAL L.P. | 141,020 | $31,328,000 | 24.16% |
Ratan Capital Management LP | 1,038,033 | $230,599,000 | 21.97% |
Marble Arch Investments | 1,069,000 | $237,478,000 | 20.47% |
Arrow Capital Management, LLC | 144,461 | $32,092,000 | 18.04% |
Tesuji Partners | 1,368,040 | $303,910,000 | 17.93% |
ValueAct Holdings | 14,994,261 | $3,330,975,000 | 17.54% |